Kangmei Pharmaceutical Co Ltd is a renowned company in the pharmaceutical industry. With a strong emphasis on integrity, innovation, and customer satisfaction, Kangmei Pharmaceutical Co Ltd prides itself on its commitment to providing high-quality products and services. The company believes in maintaining a harmonious relationship between employees, customers, and shareholders. Through continuous research and development, Kangmei Pharmaceutical Co Ltd strives to introduce cutting-edge technologies and products to improve global healthcare. By promoting humanitarian principles and sustainable growth, Kangmei Pharmaceutical Co Ltd aims to contribute to the betterment of society while ensuring profitability and long-term success.

Kangmei Pharmaceutical Co Ltd primarily operates in China, with a strong presence throughout the country. The company's headquarters is located in Shenzhen, Guangdong Province, China. Kangmei Pharmaceutical Co Ltd has a vast distribution network that covers various regions within China, including major cities and provinces. With a focus on the domestic market, Kangmei Pharmaceutical Co Ltd has established numerous production bases nationwide, ensuring its presence and accessibility across different regions of China.

Kangmei Pharmaceutical Co Ltd, a leading pharmaceutical company, has achieved several significant milestones. The company has demonstrated remarkable growth in recent years, expanding its product portfolio and market presence. Kangmei Pharmaceutical Co Ltd has successfully developed and launched innovative drugs, contributing to advancements in medical treatments. Additionally, the company has established strategic partnerships and collaborations, enhancing its research and development capabilities. With a commitment to quality and innovation, Kangmei Pharmaceutical Co Ltd has gained recognition in the industry and has become a trusted name in the pharmaceutical sector.

Kangmei Pharmaceutical Co Ltd, a renowned Chinese company, was founded in 1997. With more than two decades of experience, Kangmei Pharmaceutical has become a leading player in the pharmaceutical industry. The company specializes in the research, development, production, and distribution of various healthcare products, including traditional Chinese medicine, chemical pharmaceuticals, biological products, and medical devices. Kangmei Pharmaceutical focuses on innovation, quality, and efficiency, striving to provide safe and effective medical solutions to improve people's health and well-being. The company has built a strong reputation both domestically and internationally for its commitment to scientific research, stringent quality standards, and sustainable development practices. With a vast product portfolio and a global presence, Kangmei Pharmaceutical continues to pursue technological advancements and strategic collaborations to further strengthen its position in the pharmaceutical market.

The main competitors of Kangmei Pharmaceutical Co Ltd in the market include companies such as Shanghai Pharmaceuticals Holding Co Ltd, China Resources Sanjiu Medical & Pharmaceutical Co Ltd, and Jiangsu Hengrui Medicine Co Ltd.

Kangmei Pharmaceutical Co Ltd primarily operates in the pharmaceutical industry.

The business model of Kangmei Pharmaceutical Co Ltd revolves around pharmaceutical manufacturing, sales, and distribution. As a leading Chinese pharmaceutical company, Kangmei focuses on research, production, and marketing of a wide range of medicinal products. With a comprehensive product portfolio covering areas such as Chinese herbal medicine, prescription drugs, and health products, Kangmei delivers accessible and affordable healthcare solutions to consumers. By emphasizing technological innovation, quality control, and strategic partnerships, Kangmei seeks to constantly improve its product offering, expand market reach, and enhance overall customer satisfaction.

KGV za Kangmei Pharmaceutical Co trenutno ne može biti izračunato.

KUV za Kangmei Pharmaceutical Co trenutno ne može biti izračunat.

AlleAktien kvalitativni skor za Kangmei Pharmaceutical Co je 2/10.

Prihod trenutno ne može biti izračunat za Kangmei Pharmaceutical Co.

Profit trenutno ne može biti izračunat za Kangmei Pharmaceutical Co.

Kangmei Pharmaceutical Co Ltd is a Chinese company that was founded in 1997 and is headquartered in Lianyungang City. The company operates in the pharmaceutical industry and manufactures a wide range of drugs, dietary supplements, and medical devices. The business model of Kangmei Pharmaceutical consists of various divisions that focus on different product categories. The main business areas are the production of traditional Chinese medicines, modern pharmaceutical products, medical devices, and health products. All of these divisions are the result of ongoing research and development to ensure the quality and efficacy of the products. Kangmei's traditional Chinese medicines are highly popular and well-known in China. These are plant extracts that have been used in Chinese medicine for centuries to treat diseases. These medicines are available in various forms, including powders, tablets, capsules, and liquids. Kangmei Pharmaceutical also produces a variety of modern pharmaceutical products made from synthetic compounds. These products can be found in all major therapy areas such as cancer, cardiovascular diseases, diabetes, and infectious diseases. The company is very active in the Chinese market but is also exploring opportunities to distribute its products internationally. In addition to manufacturing drugs, Kangmei also produces medical devices. These are instruments and equipment used in diagnosis and therapy to improve the patient's health condition. There are also medical devices used in the fitness industry. Finally, Kangmei Pharmaceutical also produces a range of dietary supplements and health products. These products are naturally derived from plants and other natural sources and help promote health and prevent diseases. Kangmei's products are of high quality and meet the requirements of regulatory authorities such as the US FDA and the European EMA. Furthermore, the company is committed to researching products that meet the needs of people worldwide. It collaborates with leading universities and research institutes to find innovative solutions to existing health problems. Overall, Kangmei Pharmaceutical has a wide product portfolio catering to different markets and customer needs. Through continuous innovation and dedicated research, the company strives to improve the health of people worldwide.

Kangmei Pharmaceutical Co isplaćuje dividendu od 0 CNY raspoređenu preko isplata u toku godine.

Dividenda za Kangmei Pharmaceutical Co trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Kangmei Pharmaceutical Co je CNE0000017M1.

Oznaka za praćenje akcija kompanije Kangmei Pharmaceutical Co je 600518.SS.

U poslednjih 12 meseci, Kangmei Pharmaceutical Co je isplatio dividendu u iznosu od 0,02 CNY . To odgovara dividendnom prinosu od oko 0,91 %. Za narednih 12 meseci, Kangmei Pharmaceutical Co će verovatno isplatiti dividendu od 0 CNY.

Dividendski prinos od Kangmei Pharmaceutical Co trenutno iznosi 0,91 %.

Kangmei Pharmaceutical Co isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima јун, јул, август, септембар.

Kangmei Pharmaceutical Co je isplaćivao dividendu svake godine u poslednjih 0 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0 CNY. To odgovara dividendnom prinosu od 0 %.

Kangmei Pharmaceutical Co se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Kangmei Pharmaceutical Co od 28. 8. 2019. u iznosu od 0,024 CNY, morali ste da imate akciju u depou pre Ex-dana 28. 8. 2019..

Isplata poslednje dividende izvršena je 28. 8. 2019..

U godini 2023 kompanija Kangmei Pharmaceutical Co je isplatila 0 CNY kao dividende.

Dividende od Kangmei Pharmaceutical Co se isplaćuju u CNY.